本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corcept医疗

120.70
-0.4950-0.41%
成交量:22.90万
成交额:2,770.60万
市值:130.47亿
市盈率:266.05
高:122.08
开:121.20
低:119.28
收:121.19
52周最高:126.38
52周最低:28.66
股本:1.08亿
流通股本:9,644.01万
量比:0.46
换手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):0.4537
每股收益(LYR):0.8200
净资产收益率:8.23%
总资产收益率:0.47%
市净率:18.49
市盈率(LYR):147.19

数据加载中...

2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/21

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/19

重要事件披露

Form 8-K - Current report
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities